As of 2025-11-01, the EV/EBITDA ratio of AtriCure Inc (ATRC) is -292.16. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AtriCure's latest enterprise value is 1,669.09 mil USD. AtriCure's TTM EBITDA according to its financial statements is -5.71 mil USD. Dividing these 2 quantities gives us the above AtriCure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.0x - 14.9x | 12.0x |
| Forward P/E multiples | 17.1x - 24.3x | 18.6x |
| Fair Price | (1.00) - (0.74) | (0.79) |
| Upside | -102.9% - -102.1% | -102.3% |
| Date | EV/EBITDA |
| 2025-10-31 | -292.16 |
| 2025-10-30 | -288.16 |
| 2025-10-29 | -299.90 |
| 2025-10-28 | -308.69 |
| 2025-10-27 | -308.86 |
| 2025-10-24 | -318.17 |
| 2025-10-23 | -316.86 |
| 2025-10-22 | -314.43 |
| 2025-10-21 | -313.47 |
| 2025-10-20 | -317.47 |
| 2025-10-17 | -314.86 |
| 2025-10-16 | -315.56 |
| 2025-10-15 | -313.73 |
| 2025-10-14 | -299.46 |
| 2025-10-13 | -301.29 |
| 2025-10-10 | -306.34 |
| 2025-10-09 | -308.86 |
| 2025-10-08 | -296.77 |
| 2025-10-07 | -288.42 |
| 2025-10-06 | -293.72 |
| 2025-10-03 | -294.42 |
| 2025-10-02 | -289.89 |
| 2025-10-01 | -289.37 |
| 2025-09-30 | -298.25 |
| 2025-09-29 | -294.94 |
| 2025-09-26 | -297.81 |
| 2025-09-25 | -296.33 |
| 2025-09-24 | -305.55 |
| 2025-09-23 | -310.34 |
| 2025-09-22 | -317.99 |
| 2025-09-19 | -308.51 |
| 2025-09-18 | -310.51 |
| 2025-09-17 | -296.16 |
| 2025-09-16 | -304.42 |
| 2025-09-15 | -292.85 |
| 2025-09-12 | -296.68 |
| 2025-09-11 | -318.34 |
| 2025-09-10 | -297.38 |
| 2025-09-09 | -305.73 |
| 2025-09-08 | -304.77 |
| 2025-09-05 | -299.38 |
| 2025-09-04 | -301.81 |
| 2025-09-03 | -294.07 |
| 2025-09-02 | -307.29 |
| 2025-08-29 | -313.38 |
| 2025-08-28 | -315.38 |
| 2025-08-27 | -316.08 |
| 2025-08-26 | -321.04 |
| 2025-08-25 | -320.78 |
| 2025-08-22 | -319.21 |